| Literature DB >> 29670281 |
Ievgenia Pastushenko1, Audrey Brisebarre1, Alejandro Sifrim2,3, Marco Fioramonti1, Tatiana Revenco1, Soufiane Boumahdi1, Alexandra Van Keymeulen1, Daniel Brown2,4, Virginie Moers1, Sophie Lemaire1, Sarah De Clercq5, Esmeralda Minguijón5, Cédric Balsat6, Youri Sokolow7, Christine Dubois1, Florian De Cock1, Samuel Scozzaro1, Federico Sopena8, Angel Lanas9, Nicky D'Haene5, Isabelle Salmon5, Jean-Christophe Marine4,10, Thierry Voet2,3, Panagiota A Sotiropoulou1, Cédric Blanpain11,12.
Abstract
In cancer, the epithelial-to-mesenchymal transition (EMT) is associated with tumour stemness, metastasis and resistance to therapy. It has recently been proposed that, rather than being a binary process, EMT occurs through distinct intermediate states. However, there is no direct in vivo evidence for this idea. Here we screen a large panel of cell surface markers in skin and mammary primary tumours, and identify the existence of multiple tumour subpopulations associated with different EMT stages: from epithelial to completely mesenchymal states, passing through intermediate hybrid states. Although all EMT subpopulations presented similar tumour-propagating cell capacity, they displayed differences in cellular plasticity, invasiveness and metastatic potential. Their transcriptional and epigenetic landscapes identify the underlying gene regulatory networks, transcription factors and signalling pathways that control these different EMT transition states. Finally, these tumour subpopulations are localized in different niches that differentially regulate EMT transition states.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29670281 DOI: 10.1038/s41586-018-0040-3
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962